Klingman & Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $675K | Buy |
1,665
+120
| +8% | +$48.7K | 0.04% | 141 |
|
|
2025
Q1 | $769K | Sell |
1,545
-642
| -29% | -$319K | 0.05% | 119 |
|
|
2024
Q4 | $1.14M | Sell |
2,187
-950
| -30% | -$494K | 0.07% | 96 |
|
|
2024
Q3 | $1.94M | Buy |
3,137
+2,353
| +300% | +$1.46M | 0.12% | 75 |
|
|
2024
Q2 | $434K | Buy |
784
+232
| +42% | +$128K | 0.03% | 150 |
|
|
2024
Q1 | $321K | Buy |
552
+28
| +5% | +$16.3K | 0.02% | 186 |
|
|
2023
Q4 | $278K | Sell |
524
-59
| -10% | -$31.3K | 0.02% | 190 |
|
|
2023
Q3 | $295K | Buy |
583
+144
| +33% | +$72.9K | 0.02% | 181 |
|
|
2023
Q2 | $229K | Buy |
439
+21
| +5% | +$11K | 0.02% | 197 |
|
|
2023
Q1 | $241K | Sell |
418
-13
| -3% | -$7.49K | 0.02% | 176 |
|
|
2022
Q4 | $237K | Buy |
+431
| New | +$237K | 0.02% | 179 |
|
|
2022
Q3 | – | Sell |
-369
| Closed | -$200K | – | 201 |
|
|
2022
Q2 | $200K | Buy |
369
+11
| +3% | +$5.96K | 0.02% | 188 |
|
|
2022
Q1 | $211K | Sell |
358
-44
| -11% | -$25.9K | 0.02% | 196 |
|
|
2021
Q4 | $268K | Buy |
+402
| New | +$268K | 0.02% | 153 |
|
|
2016
Q4 | – | Sell |
-691
| Closed | -$110K | – | 295 |
|
|
2016
Q3 | $110K | Hold |
691
| – | – | 0.03% | 131 |
|
|
2016
Q2 | $102K | Hold |
691
| – | – | 0.03% | 139 |
|
|
2016
Q1 | $98K | Sell |
691
-1,675
| -71% | -$238K | 0.04% | 144 |
|
|
2015
Q4 | $336K | Hold |
2,366
| – | – | 0.13% | 78 |
|
|
2015
Q3 | $289K | Buy |
2,366
+1,675
| +242% | +$205K | 0.11% | 84 |
|
|
2015
Q2 | $90K | Hold |
691
| – | – | 0.04% | 140 |
|
|
2015
Q1 | $93K | Hold |
691
| – | – | 0.04% | 134 |
|
|
2014
Q4 | $86K | Buy |
+691
| New | +$86K | 0.04% | 140 |
|